Status:
UNKNOWN
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
Lead Sponsor:
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
Collaborating Sponsors:
Department of Health
Conditions:
Dyskinesia, Drug-Induced
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia
Detailed Description
Objective:A few case reports on the use of aripiprazole in neuroleptic-induced tardive dyskinesia have demonstrated positive effects. However its effectiveness in treatment of TD was still inconclusiv...
Eligibility Criteria
Inclusion
- Female patients must agree to prevent from being pregnant during trial periods
- Meet psychotic disorder or mood disorder criteria of DSM-IV
- Patients must have psychiatric diseases that need to use antipsychotics for a long time
- They must meet DSM-IV research criteria for neuroleptics induce tardive dyskinesia
- No clinical significant major systemic diseases
- No special neurological diseases which would influence the assessment for EPS or TD
- Mentality is better than mild mental retardation
- Patients or .legal representatives agree to join in the research and sign informed consent.
Exclusion
- Unstable major systemic diseases
- Had neurological disorder influenced to EPS assessment
- Substance abuse or dependence other then coffee or tobacco within 6 months before study
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00837707
Start Date
June 1 2008
End Date
February 1 2010
Last Update
February 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taoyuan Mental Hospital
Taoyuan District, Taiwan, 330